User Stats

Total reviews: 1
Level: Guru
Member Since: 24/11/2021

Profile Information

First name Daniel
Last name Massó
I have professional experience in:

Biotech, Cancer therapeutics, Clinical trials, Drug Delivery, Drug Discovery, Oncology, Personalised medicine, Therapeutics, animal cell culture, cell biology, genetics, molecular biology, drug delivery, proteins

Help us confirm that you're an expert

I am currently a Scientist & Project Manager at Peptomyc S.L., a spin-off company of the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Catalonia, Spain. My studies include a Biology Degree (2009), a Master in Advanced Genetics (2010) and a PhD in Oncology (Biochemistry, Molecular Biology and Biomedicine Program at the Autonomous University of Barcelona, 2017). I have worked on cancer research for over a decade and I have been involved in two main projects. The first one consisted on the repurposing of a BTK inhibitor (Ibrutinib) for the treatment of pancreatic cancer, which contributed to the initiation of a clinical trial. The second one was focused on understanding the role of the MYC oncogene in breast cancer and contributing to the development of a first-in-class MYC inhibitor (Omomyc) which is now in clinical trials. Besides coordinating the breast cancer research program at Peptomyc, I manage the preclinical toxicity studies, pharmacokinetic studies and study drug logistics.

LinkedIn

http://www.linkedin.com/in/daniel-mass%C3%B3-vall%C3%A9s-b07835ba

How did you hear about us?

Through a friend

Base
Name

Daniel Massó-Vallés

I have professional experience in:

Biotech, Cancer therapeutics, Clinical trials, Drug Delivery, Drug Discovery, Oncology, Personalised medicine, Therapeutics, animal cell culture, cell biology, genetics, molecular biology, drug delivery, proteins

Help us confirm that you're an expert

I am currently a Scientist & Project Manager at Peptomyc S.L., a spin-off company of the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Catalonia, Spain. My studies include a Biology Degree (2009), a Master in Advanced Genetics (2010) and a PhD in Oncology (Biochemistry, Molecular Biology and Biomedicine Program at the Autonomous University of Barcelona, 2017). I have worked on cancer research for over a decade and I have been involved in two main projects. The first one consisted on the repurposing of a BTK inhibitor (Ibrutinib) for the treatment of pancreatic cancer, which contributed to the initiation of a clinical trial. The second one was focused on understanding the role of the MYC oncogene in breast cancer and contributing to the development of a first-in-class MYC inhibitor (Omomyc) which is now in clinical trials. Besides coordinating the breast cancer research program at Peptomyc, I manage the preclinical toxicity studies, pharmacokinetic studies and study drug logistics.

LinkedIn

http://www.linkedin.com/in/daniel-mass%C3%B3-vall%C3%A9s-b07835ba

How did you hear about us?

Through a friend